98P Olaparib (O) in patients (pts) with solid tumors with BRCA1/2 mutation (mut): Results from the targeted agent and profiling utilization registry (TAPUR) study
| Autor: | Ahn, E., Rothe, M., Mangat, P.K., Garrett-Mayer, E., Al Baghdadi, T., Baron, A.D., Krauss, J.C., Balmanoukian, A.S., Bauman, J.R., Hameed, M.K., Mileham, K.F., Thota, R., Gold, P.J., Meric-Bernstam, F., Powell, S.F., Yang, E.S., O'Lone, R., Grantham, G.N., Halabi, S., Schilsky, R.L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S583-S584 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|